Ascent Wealth Partners, LLC Abb Vie Inc. Transaction History
Ascent Wealth Partners, LLC
- $735 Million
- Q1 2025
A detailed history of Ascent Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 62,974 shares of ABBV stock, worth $12 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
62,974
Previous 59,842
5.23%
Holding current value
$12 Million
Previous $10.6 Million
24.09%
% of portfolio
1.8%
Previous 1.44%
Shares
46 transactions
Others Institutions Holding ABBV
# of Institutions
4,251Shares Held
1.27BCall Options Held
16.5MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA174MShares$33.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.3 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.87 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $338B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...